Despite CD47 CAR-T effectiveness in xenograft mouse models with solid tumors (110), no published studies have examined CAR-T cells targeting CD47 for the treatment of CTCL patients. Here, CD47 is linked to primary cutaneous T-cell non-Hodgkin lymphoma.